Categories AlphaGraphs, Earnings, Health Care
Key highlights from Pfizer (PFE) Q2 2020 earnings results
Pfizer Inc. (NYSE:PFE) reported second quarter 2020 earnings results today.

Revenues fell 11% to $11.8 billion. The decline was 9% on an operational basis. The top line number saw an impact of 4% from COVID-19, reflecting disruption to wellness visits for patients in the US as well as lower demand for certain products in China.
On a reported basis, net income fell more than 30% to $3.4 billion, or $0.61 per share. On an adjusted basis, net income dropped 3% to $4.4 billion and EPS declined 2% to $0.78.
The company raised its guidance for fiscal year 2020 and now expects revenues to be $48.6-50.6 billion and adjusted EPS to be $2.85-2.95.
Past Performance
Click here to access the transcript for Pfizer Q2 2020 earnings conference call
Most Popular
Tyson Foods (TSN) Q1 2023 Earnings: Key financials and quarterly highlights
Tyson Foods Inc. (NYSE: TSN) reported first quarter 2023 earnings results today. Sales rose 2.5% year-over-year to $13.2 billion. Net income attributable to Tyson was $316 million, or $0.88 per
After weak start to 2023, Apple (AAPL) sees some bright spots
Apple Inc. (NASDAQ: AAPL) this week reported its first revenue decline in more than three years, even as the high inflation continues to squeeze customers’ spending power. Sales of the
Earnings: Qualcomm (QCOM) Q1 profit falls on lower revenues
Chipmaker Qualcomm, Inc. (NASDAQ: QCOM) has reported lower earnings and revenues for the first quarter of 2023. The company also provided guidance for the second quarter of 2023. At $9.5